Ask ImmunoGen CEO Dan Junius why an experimental drug called IMGN853 is important for the company, and he will tell you it’s the company’s best shot at having a wholly-owned medicine on the market in coming years. But ask him why it’s important for patients with ovarian cancer, and he will cite some striking statistics. While development of cancer drugs has come a long way in the past 10 years, most of the advancements have been in blood cancers.

NEXT
BING NEWS:
  • Plant virus treatment shows promise in fighting metastatic cancers in mice
    An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study. The treatment, composed of nanoparticles fashioned ...
    05/13/2024 - 4:38 am | View Link
  • Outsmarting Ovarian Cancer
    Biochemist Sharon Stack hopes to advance the field of ovarian cancer by exploring the tumor and host-related factors that influence its metastatic process.
    05/8/2024 - 5:12 am | View Link
  • New Hope for Ovarian Cancer: FDA Approves Targeted Drug ELAHERE for Certain Patients With Difficult-to-Manage Disease
    has been approved for the treatment of certain types of ovarian cancer by the US Food and Drug Administration (FDA). ELAHERE is the brand name for the medication known as mirvetuximab ...
    03/25/2024 - 8:15 am | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News